Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI USA Health Care |
| Investment focus | Equity, United States, Health Care |
| Fund size | EUR 839 m |
| Total expense ratio | 0.12% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 17.55% |
| Inception/ Listing Date | 12 September 2017 |
| Distribution policy | Distributing |
| Distribution frequency | Annually |
| Fund domicile | Ireland |
| Fund Provider | Xtrackers |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | State Street Custodial Services (Ireland) Limited |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revision Company | Pricewaterhouse Coopers |
| Fiscal Year End | 31 December |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| Eli Lilly & Co. | 12.35% |
| Johnson & Johnson | 8.31% |
| AbbVie, Inc. | 8.01% |
| UnitedHealth Group | 5.87% |
| Abbott Laboratories | 4.31% |
| Merck & Co., Inc. | 4.20% |
| Thermo Fisher Scientific | 3.73% |
| Amgen, Inc. | 2.98% |
| Intuitive Surgical | 2.92% |
| Pfizer Inc. | 2.87% |
| United States | 95.76% |
| Ireland | 2.70% |
| Other | 1.54% |
| Health Care | 98.46% |
| Other | 1.54% |
| YTD | +2.78% |
| 1 month | +5.20% |
| 3 months | +8.91% |
| 6 months | +17.57% |
| 1 year | +0.79% |
| 3 years | +13.42% |
| 5 years | +49.42% |
| Since inception (MAX) | +119.30% |
| 2025 | +1.00% |
| 2024 | +8.81% |
| 2023 | -1.64% |
| 2022 | +2.98% |
| Current dividend yield | 1.26% |
| Dividends (last 12 months) | EUR 0.69 |
| Period | Dividend in EUR | Dividend yield in % |
|---|---|---|
| 1 Year | EUR 0.69 | 1.25% |
| 2025 | EUR 0.69 | 1.29% |
| 2024 | EUR 0.65 | 1.30% |
| 2023 | EUR 0.61 | 1.19% |
| 2022 | EUR 0.84 | 1.65% |
| Volatility 1 year | 17.55% |
| Volatility 3 years | 14.68% |
| Volatility 5 years | 16.00% |
| Return per risk 1 year | 0.05 |
| Return per risk 3 years | 0.29 |
| Return per risk 5 years | 0.52 |
| Maximum drawdown 1 year | -21.84% |
| Maximum drawdown 3 years | -21.84% |
| Maximum drawdown 5 years | -21.84% |
| Maximum drawdown since inception | -27.86% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XUHC | - - | - - | - |
| Stuttgart Stock Exchange | EUR | XUHC | - - | - - | - |
| London Stock Exchange | GBX | XSHC | XSHC LN XUHCEUIV | XSHC.L XUHCEURINAV=SOLA | |
| London Stock Exchange | USD | XUHC | XUHC LN XUHCUSIV | XUHC.L XUHCUSDINAV=SOLA | |
| SIX Swiss Exchange | USD | XUHC | XSHCGBIV | XSHCINAV=SOLA | |
| SIX Swiss Exchange | CHF | XUHC | XUHC SW XSHCGBIV | XUHC.S XSHCINAV=SOLA | |
| XETRA | EUR | XUHC | XUHC GY | XUHC.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 46 | 0.35% p.a. | Distributing | Sampling |